FDA Approved: TUKYSA — Original Application (SEAGEN INC.)

View source ↗

Summary

FDA approves TUKYSA (tucatinib) in an original application for adults with HER2-positive metastatic breast cancer, including those with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tukysa (tucatinib)

Snippet

ORIG AP for TUKYSA (TUCATINIB)